Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): outcomes and associated factors

Milas, Sandrine; Poncelet, Arthur; Buttafuoco, F; Pardo, Antonelle; Lali, Salah Eddine; Cherifi, Soraya

doi:10.1080/17843286.2021.1916300

Cited by 11 publications

(10 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One reason might be excessive usage of antimicrobial therapy ( 6 ) leading to a reduced detection rate of pathogens in culture ( 7 ). Another possible explanation ( 2 ) is the lack of screening for fungal infections, especially for Candida species, leading to underdiagnosis of this pathogen.…”

Section: Introductionmentioning

confidence: 99%

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19

et al. 2022

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19

et al. 2022

View full text Add to dashboard Cite

show abstract

“…This review included data from more than 30 000 individuals. A Belgian study last year on 164 COVID -positive patients found that 61% of them also received an antibacterial treatment, which ultimately did not lower the mortality rate (15.2% of whom were admitted to intensive care and 15.9% of whom passed away while hospitalized) [24].…”

Section: The Role Of Covid 19 In the Resistance Of Uropathogenic Bact...mentioning

confidence: 99%

The impact of the COVID pandemic on the uropathogenic bacterial resistance profile: Experience of the bacteriology lab of the military hospital Avicenne in Marrakech

OMARI¹,

SAKHI²,

MILOUDI³

et al. 2023

GSC Adv. Res. Rev.

View full text Add to dashboard Cite

The aim of this study is to define the uropathogenic bacterial resistance and to clarify how the COVID 19 pandemic has affected the development of bacterial resistance. Patients and methods: We conducted a retrospective analysis of the bacterial profile and antibiotic resistance status of the main isolates of uropathogens at the laboratory of microbiology at the military hospital Avicenne in Marrakech over the course of two time periods: the first was prior to COVID 19 (January 2019 to February 2020), and the second was one year later (January 2021 to February 2022). Results: In the first phase of the study, out of 4000 ECBU intended for the bacteriology lab, 581 met the criteria for a urinary tract infection. In the second phase of the study, out of 4692 ECBU requested, 590 samples were found to be positive, with a rate of incidence of 15%. For the two times, the Enterobacteries made up 80% of all the isolated bacteria. The total number of multiresistant bacteria (BMR) discovered on the ECBU's isolats during the course of the two study periods is 153, or 6.5% of the total isolats. Conclusion: This study made Escherichia coli the bacteria most implicated in the epidemiology of urogenital infections during the two periods. In the majority of cases, rates of resistance to various antibiotics increased during the COVID pandemic compared to the same time period two years earlier.

show abstract

“…Question: Are radiological findings useful to predict bRTI in hospitalized COVID-19 patients? (Table 2) Since the start of the pandemic, different authors have addressed radiological markers as driver of antibiotic prescribing in COVID-19 patients [16,74,88]. For example, in a retrospective cohort study, including 429 patients with COVID-19, 51% of the 171 antibiotic prescriptions were initiated due to presence of 'radiological consolidation' on chest computed tomography [75].…”

Section: Radiological Markersmentioning

confidence: 99%

Using risk factors and markers to predict bacterial respiratory co-/superinfections in COVID-19 patients: is the antibiotic steward’s toolbox full or empty?

Laethem

Pierreux

Wuyts

et al. 2023

Acta Clinica Belgica

View full text Add to dashboard Cite

Background: Adequate diagnosis of bacterial respiratory tract co-/superinfection (bRTI) in COVID-19 patients is challenging, as there is insufficient knowledge about the role of risk factors and (para)clinical parameters in the identification of bacterial co-/superinfection in the COVID-19 setting. Empirical antibiotic therapy is mainly based on COVID-19 severity and expert opinion, rather than on scientific evidence generated since the start of the pandemic. Purpose: Reporting the best available evidence regarding the predictive value of risk factors and (para)clinical markers in the diagnosis of bRTI in COVID-19 patients. Methods: A multidisciplinary team identified different potential risk factors and (para)clinical predictors of bRTI in COVID-19 and formulated one or two research questions per topic. After a thorough literature search, research gaps were identified and suggestions concerning further research were formulated. The quality of this narrative review was ensured by following the Scale for the Assessment of Narrative Review Articles (SANRA). Results: Taking into account the scarcity of scientific evidence for markers and risk factors of bRTI in COVID-19 patients, to date, COVID-19 severity is the only parameter which can be associated with higher risk of developing bRTI. Conclusions: Evidence on the usefulness of risk factors and (para)clinical factors as predictors of bRTI in COVID-19 patients is scarce. Robust studies are needed to optimise antibiotic prescribing and stewardship activities in the context of COVID-19.

show abstract

Antibiotic use in patients with Coronavirus disease 2019 (COVID-19): outcomes and associated factors

Cited by 11 publications

References 26 publications

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19

The impact of the COVID pandemic on the uropathogenic bacterial resistance profile: Experience of the bacteriology lab of the military hospital Avicenne in Marrakech

Using risk factors and markers to predict bacterial respiratory co-/superinfections in COVID-19 patients: is the antibiotic steward’s toolbox full or empty?

Contact Info

Product

Resources

About